Compounds > 4-butyrolactone
Page last updated: 2024-08-18

4-butyrolactone and Diabetic Neuropathies

4-butyrolactone has been researched along with Diabetic Neuropathies in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Filipek, B; Gawlik, K; Malawska, B; Pawlica-Gosiewska, D; Sałat, K; Solnica, B; Więckowski, K; Witalis, J1
Sałat, K; Sałat, R1

Other Studies

2 other study(ies) available for 4-butyrolactone and Diabetic Neuropathies

ArticleYear
Evaluation of antinociceptive and antioxidant properties of 3-[4-(3-trifluoromethyl-phenyl)-piperazin-1-yl]-dihydrofuran-2-one in mice.
    Naunyn-Schmiedeberg's archives of pharmacology, 2013, Volume: 386, Issue:6

    Topics: 4-Butyrolactone; Analgesics; Animals; Antioxidants; Brain; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disease Models, Animal; Male; Mice; Pain; Pain Threshold; Piperazines; Streptozocin

2013
The application of support vector regression for prediction of the antiallodynic effect of drug combinations in the mouse model of streptozocin-induced diabetic neuropathy.
    Computer methods and programs in biomedicine, 2013, Volume: 111, Issue:2

    Topics: 4-Butyrolactone; Algorithms; Analgesics; Animals; Computer Simulation; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Drug Administration Schedule; Drug Combinations; Furans; gamma-Aminobutyric Acid; Hyperalgesia; Male; Mice; Pain; Pain Measurement; Pain Threshold; Piperazines; Pregabalin; Software; Streptozocin; Support Vector Machine; Time Factors

2013